You are here
Pfizer boosts China presence with US$350m biotech plant
PFIZER Inc will invest US$350 million in eastern China on a plant for biotechnology drugs, bolstering its presence in the world's second largest pharmaceutical market despite slowing economic growth in the country and rising pressure on prices for medicines.
- CALL +65 6388 3838
- EMAIL email@example.com